Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of COVID-19 vaccines among lung transplant recipients
jRCT1021210009Recruiting
- Sponsor
- Yoshinori Okada
- Start
- Jun 2021
- Countries
- 1
01
Overview
Open-label trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Yoshinori Okada. Primary endpoint: Efficacy of COVID-19 vaccine. Started Jun 2021; status: recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on jRCT1021210009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1021210009.